Lungs News and Research

RSS

Proton therapy to treat patient’s tumor without compromising quality of life

The radiation oncologist's mantra is to deliver the maximum dose of radiation to the malignant tumor, while limiting damage to healthy surrounding tissue. In proton therapy, this balance is achieved by using proton particles, accelerated to nearly the speed of light, to mimic the shape of a tumor and effectively deposit their energy within the confines of it with sub-millimeter precision.

4 Aug 2010

Study analyzes prevalence of pediatric patient-safety events at hospitals

Hospital-acquired infections are the leading cause of potentially preventable mortality among pediatric patients, according to a study of pediatric patient-safety incidents issued today by HealthGrades, the leading independent health care ratings organization.

4 Aug 2010

Premier international conference to discuss latest diagnostic tools, emerging therapies for personalized medicine

What As scientists understand more about a tumor's underlying biology, personalized medicine is emerging as the new patient management paradigm. This year, the American Association for Cancer Research will host its fourth Molecular Diagnostics in Cancer Therapeutic Development: Challenges and Horizons conference at the Sheraton Denver Downtown Hotel in Denver, Colo. This meeting regularly draws representatives from academia and industry to discuss the latest in diagnostic tools and emerging therapies.

4 Aug 2010

Accuray receives Shonin approval to market CyberKnife G4 Robotic Radiosurgery System

Accuray Incorporated, a global leader in the field of radiosurgery, announced today it received Shonin approval from the Japanese Ministry of Health, Labor and Welfare to market the CyberKnife G4 Robotic Radiosurgery System to treat tumors non-invasively anywhere in the body, inclusive of head and neck. The System will be marketed in Japan as the "CyberKnife Radiosurgery System."

3 Aug 2010

Acorda second-quarter net loss decreases to $6.8 million

Acorda Therapeutics, Inc. today announced its financial results for the second quarter of 2010.

3 Aug 2010

Research findings help shape long-term follow-up strategies for early stage lung cancer patients

In patients with non-small cell lung cancer, five-year disease-free survival is currently the benchmark of cure. However, there are two issues that remain with the follow-up standards: (1) When can cure be declared with confidence and (2) for how long should follow-up examination be continued?

3 Aug 2010

Study shows prevalence, severity of dyspnea in long-term lung cancer survivors

With the growing number of long-term lung cancer survivors, research is needed to identify and address cancer survivorship issues. One of the most common and debilitating symptoms among lung cancer patients is dyspnea, or shortness of breath. As most studies of dyspnea have reviewed patients with active lung cancer or immediately after treatment, the prevalence of dyspnea over the long-term once treatment has been completed is not well characterized.

3 Aug 2010

ArQule, Daiichi Sankyo announce decision to advance ARQ 197 into Phase 3 clinical trial for NSCLC

ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced that they will move forward with a Phase 3 clinical trial of ARQ 197, a small molecule inhibitor of the c-Met receptor tyrosine kinase, in patients with non-small cell lung cancer (NSCLC). In connection with this decision, the sponsor company, Daiichi Sankyo, will file a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) for a trial comparing ARQ 197 plus erlotinib against erlotinib plus placebo.

3 Aug 2010

Americans halved their risk of dying from CHD over past 20 years: Study

By smoking less, watching their cholesterol and lowering their high blood pressure, Americans halved their risk of dying from coronary heart disease over the past 20 years, a new study shows.

3 Aug 2010

$International study of more than 60,000 women highlights additional risk associated with fractures$

International study of more than 60,000 women highlights additional risk associated with fractures

Researchers seeking to understand the impact of osteoporosis and fractures on various aspects of health have found that women who had previous fractures experienced a significant reduction in health-related quality of life similar to or worse than that experienced by patients with diabetes, arthritis, lung disease and other chronic illnesses. This latest study from the Global Longitudinal Study of Osteoporosis in Women (GLOW), which is based at the Center for Outcomes Research at the University of Massachusetts Medical School, was published online.

3 Aug 2010

Vanguard signs definitive agreement to acquire Arizona Heart Institute

Vanguard Health Systems and Arizona Heart Institute (AHI) announced today that they have signed a definitive agreement for Vanguard to acquire Arizona Heart Institute, one of the world's leading providers of cardiovascular care. Through this agreement, AHI will align with Abrazo Health Care, a Phoenix-based subsidiary of Vanguard, to become part of its distributive cardiovascular network of community-based physicians, providing future opportunities to greatly expand cardiovascular services and patient base throughout the region.

3 Aug 2010

Alphavirus vaccine blocks tumor growth in advanced cancer: Research

An experimental vaccine based on a virus that causes encephalitis in the wild appears to block tumor growth in some cases of advanced cancer, according to researchers at Duke University Medical Center. Scientists say the vaccine is able to stimulate an immune response, even in the face of profound immune system suppression, a condition most patients with advanced cancer experience.

3 Aug 2010

Study on disparities in survival of cancer patients from different socioeconomic groups

A new analysis from Canada has found that cancer patients from poorer communities have a greater chance of dying prematurely than individuals from more affluent backgrounds even though cancer stage at time of diagnosis is similar across socioeconomic groups. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that efforts are needed to understand and reduce disparities in the survival of cancer patients from different socioeconomic groups.

2 Aug 2010

Microsulis launches Acculis percutaneous microwave tissue ablation system at ECIO

Microsulis Medical Ltd (MML), the leading company in microwave technology for medical devices, has successfully launched the Acculis percutaneous microwave tissue ablation system, Accu2i pMTA, at the second European Conference on Interventional Oncology (ECIO) in Florence, Italy. A revolutionary new device for destroying tumours, the system is a 1.8mm diameter closed water-cooled needle, with performance matching the existing Acculis open surgery MTA system.

31 Jul 2010

ZIOPHARM second-quarter net loss from operations increases to $5.1 million

ZIOPHARM Oncology, Inc., a biopharmaceutical cancer company addressing unmet medical needs, today reported its financial results for the three months ended June 30, 2010 and provided an update on the Company's continued progress with its clinical programs.

30 Jul 2010

Paperwork for reimbursement prevents PCTs access to high-cost cancer drugs

The amount of paperwork that primary care trusts (PCTs) have to fill out in order to be reimbursed for cancer drugs is so great that they may be missing out on millions of pounds, a report suggests.

30 Jul 2010

No More Excuses No More Lung Cancer 5K Run/Walk comes back to Georgia

Today, Lung Cancer Alliance-Georgia announced the return of the No More Excuses No More Lung Cancer 5K Run/Walk. Taking place on Saturday, November 6, 2010, the run/walk will raise awareness for lung cancer to help reduce the stigma of the disease, expand the grassroots movement for the disease and inspire others to join the cause to increase compassion and support to all those impacted by lung cancer

30 Jul 2010

CPF announces nationwide advertising campaign to increase awareness about PF

The Coalition for Pulmonary Fibrosis announced today a nationwide advertising campaign to spread the word about Pulmonary Fibrosis is underway in an untraditional setting – on the nation's interstates. Together, a billboard ad and truck ads are part of a nationwide campaign to raise eyebrows and awareness of the deadly lung disease.

30 Jul 2010

New findings on snake venom toxin hold promise for developing heart disease, cancer therapies

Researchers seeking to learn more about stroke by studying how the body responds to toxins in snake venom are this week releasing new findings that they hope will aid in the development of therapies for heart disease and, surprisingly, cancer. The Japanese team is reporting in a Journal of Biological Chemistry "Paper of the Week" that they are optimistic that inhibiting a protein found on the surface of blood cells known as platelets may combat both irregular blood clotting and the spread of certain cancers throughout the body.

30 Jul 2010

Researchers develop new fluorescent biosensor for drug development

Researchers at Carnegie Mellon University have developed a new fluorescent biosensor that could aid in the development of an important class of drugs that target a crucial class of proteins called G protein-coupled receptors (GPCRs).

30 Jul 2010

Lungs News and Research

Proton therapy to treat patient’s tumor without compromising quality of life

Study analyzes prevalence of pediatric patient-safety events at hospitals

Premier international conference to discuss latest diagnostic tools, emerging therapies for personalized medicine

Accuray receives Shonin approval to market CyberKnife G4 Robotic Radiosurgery System

Acorda second-quarter net loss decreases to $6.8 million

Research findings help shape long-term follow-up strategies for early stage lung cancer patients

Study shows prevalence, severity of dyspnea in long-term lung cancer survivors

ArQule, Daiichi Sankyo announce decision to advance ARQ 197 into Phase 3 clinical trial for NSCLC

Americans halved their risk of dying from CHD over past 20 years: Study

International study of more than 60,000 women highlights additional risk associated with fractures

Vanguard signs definitive agreement to acquire Arizona Heart Institute

Alphavirus vaccine blocks tumor growth in advanced cancer: Research

Study on disparities in survival of cancer patients from different socioeconomic groups

Microsulis launches Acculis percutaneous microwave tissue ablation system at ECIO

ZIOPHARM second-quarter net loss from operations increases to $5.1 million

Paperwork for reimbursement prevents PCTs access to high-cost cancer drugs

No More Excuses No More Lung Cancer 5K Run/Walk comes back to Georgia

CPF announces nationwide advertising campaign to increase awareness about PF

New findings on snake venom toxin hold promise for developing heart disease, cancer therapies

Researchers develop new fluorescent biosensor for drug development

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News